These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

362 related articles for article (PubMed ID: 18430138)

  • 21. PopB-PcrV Interactions Are Essential for Pore Formation in the Pseudomonas aeruginosa Type III Secretion System Translocon.
    Kundracik E; Trichka J; Díaz Aponte J; Roistacher A; Rietsch A
    mBio; 2022 Oct; 13(5):e0238122. PubMed ID: 36154276
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Who comes first? How plant pathogenic bacteria orchestrate type III secretion.
    Büttner D; Bonas U
    Curr Opin Microbiol; 2006 Apr; 9(2):193-200. PubMed ID: 16529983
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Assembly of the bacterial type III secretion machinery.
    Diepold A; Wagner S
    FEMS Microbiol Rev; 2014 Jul; 38(4):802-22. PubMed ID: 24484471
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Synergistic pore formation by type III toxin translocators of Pseudomonas aeruginosa.
    Faudry E; Vernier G; Neumann E; Forge V; Attree I
    Biochemistry; 2006 Jul; 45(26):8117-23. PubMed ID: 16800636
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Functional relatedness in the Inv/Mxi-Spa type III secretion system family.
    Klein JA; Dave BM; Raphenya AR; McArthur AG; Knodler LA
    Mol Microbiol; 2017 Mar; 103(6):973-991. PubMed ID: 27997726
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Yersinia enterocolitica type III secretion chaperone SycD: recombinant expression, purification and characterization of a homodimer.
    Schmid A; Dittmann S; Grimminger V; Walter S; Heesemann J; Wilharm G
    Protein Expr Purif; 2006 Oct; 49(2):176-82. PubMed ID: 16750393
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Oligomerization of type III secretion proteins PopB and PopD precedes pore formation in Pseudomonas.
    Schoehn G; Di Guilmi AM; Lemaire D; Attree I; Weissenhorn W; Dessen A
    EMBO J; 2003 Oct; 22(19):4957-67. PubMed ID: 14517235
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Type II secretion: a protein secretion system for all seasons.
    Cianciotto NP
    Trends Microbiol; 2005 Dec; 13(12):581-8. PubMed ID: 16216510
    [TBL] [Abstract][Full Text] [Related]  

  • 29. IpaD is localized at the tip of the Shigella flexneri type III secretion apparatus.
    Sani M; Botteaux A; Parsot C; Sansonetti P; Boekema EJ; Allaoui A
    Biochim Biophys Acta; 2007 Feb; 1770(2):307-11. PubMed ID: 17110044
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Supramolecular structure of the Shigella type III secretion machinery: the needle part is changeable in length and essential for delivery of effectors.
    Tamano K; Aizawa S; Katayama E; Nonaka T; Imajoh-Ohmi S; Kuwae A; Nagai S; Sasakawa C
    EMBO J; 2000 Aug; 19(15):3876-87. PubMed ID: 10921870
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The Type III Secretion Translocation Pore Senses Host Cell Contact.
    Armentrout EI; Rietsch A
    PLoS Pathog; 2016 Mar; 12(3):e1005530. PubMed ID: 27022930
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Tetratricopeptide repeats are essential for PcrH chaperone function in Pseudomonas aeruginosa type III secretion.
    Bröms JE; Edqvist PJ; Forsberg A; Francis MS
    FEMS Microbiol Lett; 2006 Mar; 256(1):57-66. PubMed ID: 16487320
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Structural overview of the bacterial injectisome.
    Worrall LJ; Lameignere E; Strynadka NC
    Curr Opin Microbiol; 2011 Feb; 14(1):3-8. PubMed ID: 21112241
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Phylogenetic analyses of the constituents of Type III protein secretion systems.
    Nguyen L; Paulsen IT; Tchieu J; Hueck CJ; Saier MH
    J Mol Microbiol Biotechnol; 2000 Apr; 2(2):125-44. PubMed ID: 10939240
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Transmembrane substrates of type three secretion system injectisomes.
    Godlee C; Holden DW
    Microbiology (Reading); 2023 Jan; 169(1):. PubMed ID: 36748571
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Molecular mechanisms of bacterial virulence: type III secretion and pathogenicity islands.
    Mecsas JJ; Strauss EJ
    Emerg Infect Dis; 1996; 2(4):270-88. PubMed ID: 8969244
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mutations in the Yersinia pseudotuberculosis type III secretion system needle protein, YscF, that specifically abrogate effector translocation into host cells.
    Davis AJ; Mecsas J
    J Bacteriol; 2007 Jan; 189(1):83-97. PubMed ID: 17071752
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The type III secretion injectisome, a complex nanomachine for intracellular 'toxin' delivery.
    Cornelis GR
    Biol Chem; 2010 Jul; 391(7):745-51. PubMed ID: 20482311
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Type III secretion systems and bacterial pathogenicity].
    Iida T
    Tanpakushitsu Kakusan Koso; 2005 Jan; 50(1):29-35. PubMed ID: 15651414
    [No Abstract]   [Full Text] [Related]  

  • 40. Assembly of the inner rod determines needle length in the type III secretion injectisome.
    Marlovits TC; Kubori T; Lara-Tejero M; Thomas D; Unger VM; Galán JE
    Nature; 2006 Jun; 441(7093):637-40. PubMed ID: 16738660
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.